Nanomaterial-driven modulation of lipid metabolism: Novel strategies toward precision obesity treatment.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41909509.
- Also identified by DOI 10.1016/j.bioactmat.2026.02.057 and PMC identifier 13019090.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Obesity treatment is entering a new era with the advent of multifunctional nanomaterials capable of precise biological intervention. This review highlights their pivotal role in overcoming key therapeutic limitations, including poor targeting, systemic toxicity, and low bioavailability. Based on the systematic analysis of lipid metabolism, we propose five strategic intervention points: reducing lipid intake, interfering with absorption, inhibiting storage, promoting consumption, and remodeling the adipose tissue microenvironment. Furthermore, we examine the application of diverse nanoplatforms in these therapeutic strategies, ranging from inorganic or polymeric nanoparticles to natural biopolymer-based nanomedicine, and demonstrate their potential in realizing precise targeting and transdermal drug delivery. By integrating mechanistic insights with advanced nanomaterial design, this work not only outlines a systematic framework for obesity nanomedicine, but also accelerates the translational path toward precision anti-obesity therapies.